“I joined the Centre for Cellular and Molecular Biology at Hyderabad in 1988 after completing my PhD in Biochemistry from the National Institute of Nutrition, Hyderabad.
Being the CEO of the Atal Incubation Centre(AIC) at the Centre for Cellular and Molecular Biology (AIC-CCMB), I certainly take responsibility to contribute to new technologies that will positively impact the life of the public, globally.
AIC-CCMB is a premier incubator focused on promoting entrepreneurship in life sciences, and supporting startups in Health, Pharmaceuticals and Biotechnology. CSIR – CCMB is one of the first 10 institutes to establish under the Atal Innovation Mission (AIM) of the National Institution for Transforming India (NITI Aayog).
Speaking about our work in the COVID-19 phase, we have developed a potential mRNA vaccine candidate against SARS-CoV-2 within 10 months of having initiated the concept and we are glad that we were able to achieve the landmark of replicating the mRNA vaccine technology end to end.
The beauty of this technology is in its rapid turnaround times, which means, vaccines can be developed for other diseases or a pan-COVID vaccine covering different variants. This initiative was taken up with the sole objective of building capacity to develop indigenous mRNA vaccine platform technology for Indian conditions.
The journey for the past two years has been challenging yet incredibly satisfying. The home-grown mRNA vaccine platform which we have developed can be altered accordingly, to deal with other infectious diseases like TB, Dengue, Chikungunya, Malaria, rare genetic diseases, and others. We are looking forward to supporting many more innovative products in order to improve healthcare as a whole in our country.”
(Humans of Hyderabad in Collaboration with Atal Incubation Centre – CCMB)
#innovation #technology #mRNA #COVID19 #science #sciencenews #tech #india #virology #development #Hyderabad #HumansoHyderabad